ES503984A0 - Un procedimiento para la preparacion de pirimidin-2-onas sustituidas - Google Patents

Un procedimiento para la preparacion de pirimidin-2-onas sustituidas

Info

Publication number
ES503984A0
ES503984A0 ES503984A ES503984A ES503984A0 ES 503984 A0 ES503984 A0 ES 503984A0 ES 503984 A ES503984 A ES 503984A ES 503984 A ES503984 A ES 503984A ES 503984 A0 ES503984 A0 ES 503984A0
Authority
ES
Spain
Prior art keywords
group
compounds
susceptible
phase
abnormal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES503984A
Other languages
English (en)
Other versions
ES8301473A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ES8301473A1 publication Critical patent/ES8301473A1/es
Publication of ES503984A0 publication Critical patent/ES503984A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES503984A 1980-07-15 1981-07-15 Un procedimiento para la preparacion de pirimidin-2-onas sustituidas Granted ES503984A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8023063 1980-07-15

Publications (2)

Publication Number Publication Date
ES8301473A1 ES8301473A1 (es) 1982-12-01
ES503984A0 true ES503984A0 (es) 1982-12-01

Family

ID=10514771

Family Applications (2)

Application Number Title Priority Date Filing Date
ES503984A Granted ES503984A0 (es) 1980-07-15 1981-07-15 Un procedimiento para la preparacion de pirimidin-2-onas sustituidas
ES513177A Granted ES513177A0 (es) 1980-07-15 1982-06-16 "un procedimiento para la preparacion de pirimidin-2-onas sustituidas".

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES513177A Granted ES513177A0 (es) 1980-07-15 1982-06-16 "un procedimiento para la preparacion de pirimidin-2-onas sustituidas".

Country Status (12)

Country Link
US (1) US4636509A (es)
EP (1) EP0044704B1 (es)
JP (1) JPS5740471A (es)
AT (1) ATE19627T1 (es)
AU (1) AU7300381A (es)
CA (1) CA1160226A (es)
DE (1) DE3174554D1 (es)
DK (1) DK315281A (es)
ES (2) ES503984A0 (es)
NO (1) NO812431L (es)
NZ (1) NZ197714A (es)
ZA (1) ZA814845B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58159479A (ja) * 1982-02-24 1983-09-21 ニユエガ−ド・アンド・コンパニ−・アクシエ／セルカペト 置換されたピリミジン−２−オン化合物
GB2135992B (en) * 1983-01-11 1986-09-24 Nyegaard & Co As Substituted pyrimidines and processes for their preparation
GB8420610D0 (en) * 1984-08-14 1984-09-19 Glaxo Group Ltd Chemical compounds
US4849426A (en) * 1987-05-15 1989-07-18 Pearlman Dale L Method for treating actinic keratosis with cytotoxic agents
US4853388A (en) * 1987-05-15 1989-08-01 Pearlman Dale L Method for treating psoriasis with cytotoxic agents
US4820711A (en) * 1987-05-15 1989-04-11 Pearlman Dale L Method for treating actinic keratosis with cytotoxic agents
US4855466A (en) * 1987-12-28 1989-08-08 E. R. Squibb & Sons, Inc. Purinyl cyclobutanes
US6334997B1 (en) 1994-03-25 2002-01-01 Isotechnika, Inc. Method of using deuterated calcium channel blockers
WO1995026325A2 (en) * 1994-03-25 1995-10-05 Isotechnika Inc. Enhancement of the efficacy of drugs by deuteration
MXPA06014131A (es) 2004-06-04 2007-03-07 Astellas Pharma Inc Derivado de propano-1,3-diona o su sal.
KR101046039B1 (ko) * 2005-03-31 2011-07-01 아스텔라스세이야쿠 가부시키가이샤 프로판-1,3-디온 유도체 또는 그의 염

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1561290A (en) * 1975-10-16 1980-02-20 Nyegaard & Co As Pyrimid - 2 - ones
ES498337A0 (es) * 1980-01-07 1982-06-01 Nyegaard & Co As Un procedimiento para la preparacion de 5-halo-pirimidin-2- onas
GB2080300B (en) * 1980-07-15 1984-04-26 Glaxo Group Ltd Substituted pyrimidin-2-ones the salts thereof processes for their preparation and pharmaceutical compositions containing them
GB2080301B (en) * 1980-07-15 1984-04-18 Glaxo Group Ltd Substituted pyrimidin-2-ones the salts thereof processes for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
EP0044704B1 (en) 1986-05-07
DK315281A (da) 1982-01-16
NO812431L (no) 1982-01-18
ES8301473A1 (es) 1982-12-01
EP0044704A1 (en) 1982-01-27
ES8307758A1 (es) 1983-07-01
ES513177A0 (es) 1983-07-01
JPS5740471A (en) 1982-03-06
NZ197714A (en) 1984-11-09
CA1160226A (en) 1984-01-10
AU7300381A (en) 1982-01-21
DE3174554D1 (en) 1986-06-12
ZA814845B (en) 1983-02-23
US4636509A (en) 1987-01-13
ATE19627T1 (de) 1986-05-15

Similar Documents

Publication Publication Date Title
DE122009000040I2 (de) Naphthalin-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
DK92781A (da) Fremgangsmaade til fremstilling af indanderivater eller syreadditionssalte deraf
ES503984A0 (es) Un procedimiento para la preparacion de pirimidin-2-onas sustituidas
FI873413A0 (fi) Fenoxiaettiksyraderivat och deras framstaellning.
DE68917220D1 (de) Phenylpyridon-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen.
FI834790A0 (fi) Foerfarande foer framstaellning av dietylaminoalkoxibenzhydrol-derivat
ATE4715T1 (de) 5-halo-pyrimidin-2-one, ihre salze, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
DK601683A (da) Dialkylaminoalkoxybenzylalkoholderivater
SE7709158L (sv) Nya substituerade 2-fenylaminoimidazolin-(2)-er, syraadditionssalter derav, lekemedel som innehaller dessa och forfarande for framstellning derav
SE7902302L (sv) Nya n-fenylalaninderivat, deras framstellning och deras anvendning som lekemedel
ES503985A0 (es) Un procedimiento para la preparacion de pirimidin-2-onas sustituidas
DK0640612T3 (da) Hidtil ukendte derivater af 2-(1H)-quinolinon, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdend
NO157214C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolcarboxylsyrederivater.